As of Jun 30, 2025, Oaktree Acquisition Corp. III Life Sciences has 3,400 shares failed to deliver, representing 4.57% of the average daily volume of 74,370 shares. Over the past year, the monthly average FTD is 2,091 shares, with the current level 63% above the historical average, indicating elevated settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.